A new spin-off of Amsterdam UMC, location AMC, HaemoPulse, started in the first months of 2019. HaemoPulse will develop non-invasive optical technology for continuous real-time monitoring of blood hematocrit.
Being able to measure hematocrit in such a manner opens a wide range of clinical applications, such as tracking of fluid balance in critically ill patients in the ICU, or monitoring of fluid retention of dialysis patients between dialysis treatments. Current clinical techniques for such measurements are insufficiently accurate or require expensive, time-consuming, lab testing of invasively acquired blood samples.
HaemoPulse intends to provide the technology that provides doctors with critical information on fluid balance and blood hematocrit that they currently lack. The scientific founder, Dr. Alan Riordan, is an AMC researcher and the company is developing the technology with the biomedical optics research group of Prof. Ton van Leeuwen at AMC.
On December 10 the Tony’s Chocolonely and fintech start up SRXP teaching cases were presented to an audience of teachers and entrepreneurs. During his presentation of the SRXP case professor Sustainable Entrepreneurship at VU Amsterdam, Enno Masurel, focused on the development from student start up to a growing and expanding company. While Maarten Hogenstijn researcher […]News
On 29 January professionals from both beta and gamma disciplines gathered at Amsterdam Science Park to share and to learn on techno-economic solutions for the conversion of carbon dioxide, carbon sequestration in agricultural soil, geo-energy supply and the re-use of plastics. The Amsterdam Green Campus brings together professionals from academia, applied science and vocational education […]News
Sign up your idea and have a chance to win € 7,500. Do you have an innovative idea and would you like to develop it further? Then consider yourself invited to participate in the 14th edition of the Amsterdam Science & Innovation Award. € 7,500 will be awarded to the best idea in each category […]News